2026 Compensation Guide

    2026 Director of Clinical Operations Compensation Guide

    Director of Clinical Operations owns trial execution: CRO oversight, site management, enrollment, vendor selection, and study budgets. ClinOps leadership is the single most cited bottleneck in mid-stage biotech execution.

    Written by Darren NelsonReviewed by Recruits Lab Research TeamUpdated 2026

    Direct Answer

    What does a Director of Clinical Operations make in 2026?

    Director of Clinical Operations at U.S. venture-backed biotech earns $210K-$290K base in 2026, plus 15-22 percent target bonus and 0.05-0.20 percent equity. Senior Directors run $260K-$340K base with 20-25 percent bonus and 0.10-0.30 percent equity. Therapeutic experience and CRO management depth drive the high end.

    Compensation data is directional and may vary based on geography, company stage, industry, equity, bonus structure, and candidate experience. This guide is an educational resource, not a definitive compensation survey.

    Compensation Bands

    Base, bonus, and equity by level. All figures are 2026 U.S. directional ranges.

    LevelBase SalaryBonus / OTEEquity
    Associate Director Clinical Operations$170K-$220K12-18% ($25K-$45K)0.03%-0.10%
    Director Clinical Operations$210K-$290K15-22% ($35K-$65K)0.05%-0.20%
    Senior Director Clinical Operations$260K-$340K20-25% ($55K-$90K)0.10%-0.30%
    VP Clinical Operations$320K-$440K25-32% ($85K-$140K)0.20%-0.50%

    Bonus Structure

    ClinOps bonuses are typically split 70/30 between corporate milestones (FPI, LPI, database lock) and individual targets. CRO performance management is increasingly tied to incentive structure.

    Equity Structure

    Equity grants at ClinOps Director level are smaller than functional peers in Clinical Development or CMC because the role is viewed as execution-critical but not strategy-defining. VPs of ClinOps reverse this curve.

    Geographic Comparisons

    Marketvs. BaselineCommentary
    Boston / Cambridge1.00x (baseline)Deepest qualified ClinOps pool in the country.
    San Francisco Bay Area0.95x-1.05xComparable to Boston. Cell/gene premium of 5-10 percent.
    Research Triangle (NC)0.85x-0.95xCRO-adjacent talent. Strong vendor management backgrounds.
    Philadelphia / NJ0.90x-1.00xPharma alumni talent pool. Strong for late-stage programs.
    Remote (US)0.88x-0.95xVery common since 2022. Roughly 70 percent of director-level searches allow remote.

    Hiring Market Commentary

    • 1

      Demand for senior ClinOps leaders with cell, gene, and radioligand therapy experience is the tightest sub-segment of the function.

    • 2

      Director-level ClinOps supply increased modestly after big pharma R&D restructurings in 2024-2025, but pivotal-trial experienced supply remained tight.

    • 3

      CRO-to-biotech transitions have become a more common hiring pattern. CRO project leads with 6+ years of sponsor-side oversight are well positioned for sponsor Director ClinOps roles.

    Talent Availability

    Tight

    Director ClinOps supply is moderate at the generalist level and tight for therapeutic-area-specific pivotal experience. Senior Director ClinOps with novel-modality experience is very tight.

    Market Indicators

    • Average time-to-hire Director: 10-14 weeks
    • Average time-to-hire Senior Director: 12-18 weeks
    • Cell/gene therapy ClinOps premium over small molecule: 10-15 percent base

    Recruits Lab Hiring Insights

    Patterns we have observed across recent placements in this market.

    • Candidates from large pharma rarely succeed in fast-moving Series A biotech without prior small-company experience. We weight prior biotech tenure heavily in shortlist screens.

    • Founders who clearly articulate CRO strategy (full-service vs. functional service provider) close ClinOps Directors faster than those who treat CRO selection as the candidate's first task.

    • ClinOps Directors who name 'shared accountability with Clinical Development' as a decision factor have a 20 percent higher retention rate in our placements.

    Frequently Asked Questions

    How much does a Senior Director of Clinical Operations make?+

    $260K-$340K base in 2026, plus 20-25 percent target bonus and 0.10-0.30 percent equity at venture-backed biotech.

    Do Clinical Operations roles allow remote work?+

    Yes. Around 70 percent of director and senior director searches we run allow primary remote with travel to HQ and clinical sites.

    What experience matters most for a biotech ClinOps Director?+

    Sponsor-side trial execution in the company's modality, prior CRO oversight (not just CRO-side execution), and proven enrollment recovery experience.

    Compensation data is directional and may vary based on geography, company stage, industry, equity, bonus structure, and candidate experience. This guide is an educational resource, not a definitive compensation survey.

    Free Strategy Review

    Need Help Hiring?

    Schedule a free 30-minute Hiring Strategy Review and walk away with a clear plan tailored to your roles.

    • Hiring market insights
    • Salary benchmarking
    • Talent availability analysis
    • Recruiting strategy recommendations
    Book Free Strategy Review